The latest Bank of America survey shows a broad consensus among professionals that US stocks and the greenback could keep ...

Why backing founder-led companies can be a fine line between genius and hubris, and how to spot the difference for your ...

For investors, few themes have ever matched the scale and urgency of climate change. Over the past two decades, the rapid ...

“We used to have a car industry – that’s gone. We're uncompetitive and people don’t want to roll up their sleeves anymore.

After a rocky week, as investors struggled to price in erratic US trade and tariff policy, markets seem to have regained their poise. Shares pushed higher all around the world on Monday after scoring ...

Talk the Fed could restart QE programs to cap bond yields if they rebound on new inflation worries has been dismissed by ...

Emerging markets are undervalued, they are underrepresented, and potentially a blind spot in many portfolios, says Orbis' Vern du Preez.

With the ability to offset the impact of tariffs and strong historical performance in tough times, the health sector could be one to watch.

How do you ever expect to find the next market darling if you're not even looking? Here's two ideas to join the hunt.

It’s tempting to lay the ASX200 travails of recent times to Liberation Day. But that would be wrong.

The economic and fundamental backdrops are still reasonably sound, but persistent inflation, higher rates, uncertainty around ...

President Trump’s trade war poses a threat to Australian economic growth particularly via the indirect impact of weaker ...